MTRTI - Overview: MatePair, Targeted Rearrangements, Oncology

Test Catalog

Test Name

Test ID: MTRTI    
MatePair, Targeted Rearrangements, Oncology

Useful For Suggests clinical disorders or settings where the test may be helpful

Second-tier testing in oncologic specimens when previous cytogenetic testing has detected an acquired chromosome abnormality of unknown significance


Determining the size, precise breakpoints, gene content, and any unappreciated complexity of abnormalities detected by other methods such as conventional chromosome and FISH studies


Providing important diagnostic, prognostic, and therapeutic information critical to proper patient management

Genetics Test Information Provides information that may help with selection of the correct genetic test or proper submission of the test request

This testing is only appropriate in individuals with previously detected acquired chromosomal abnormalities. If previous testing was performed at another institution, supply a copy of those results. If sufficient information regarding the patient's known chromosome abnormality is not made available, this testing will be cancelled.

Special Instructions and Forms Library of PDFs including pertinent information and consent forms, specimen collection and preparation information, test algorithms, and other information pertinent to test

Method Name A short description of the method used to perform the test

Mate-Pair Whole Genome Sequencing

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

MatePair, Targeted, Oncology

Aliases Lists additional common names for a test, as an aid in searching

Mate-Pair sequencing
Mate-Pair analysis
Balanced rearrangement characterization
Acquired translocation characterization
Acquired inversion characterization
Next Gen Sequencing Test
Mate Pair